januvia-lawyer-type-2-diabetes-pill-side-effects-infographic

2006 Januvia CANCER CANCER ČANČER The FDA approved Januvia for sale on the market by Merck. 2009 In April, the medical journal, Diabetes, published a study that linked GLP-1 drugs like Januvia and Byetta pancreas abnormalities that can lead to pancreatitis and pancreatic cancer. In September, the FDA received 88 reports of acute pancreatitis from patients taking Januvia. 19 of these patients developed pancreatitis within 30 days of taking the drug. Additionally, in more than 50% of the patients pancreatitis stopped when the patient stopped taking Januvia. to Januvia once-daily type-2 diabetes pill that controls glucose levels by inhibiting the DPP-4 enzyme. However, the DPP-4 enzyme suppresses tumors and inhibiting this enzyme can allow cancer to progress. Since its release, Januvia has been one of Merck's best performing drugs with $3.3 billion in sales in 2011 and $4 billion in sales in 2012. In recent years, Januvia has been linked (sitagliptin phosphate) is a 2011 to pancreatitis and pancreatic cancer. The medical journal Gastroenterology published a study that found a six fold increase of pancreatitis in patients taking Byetta and Januvia. Additionally, Januvia increased the risk of pancreatic cancer by 2.7 times. COMMON SIDE EFFECTS: Nausea 2012 Swelling The FDA received a total of 14,684 adverse event reports for Januvia. These reports included 765 cases of increased blood glucose, 625 cases of pancreatitis, and 455 cases of hyperglycaemia. 1,942 of these reports indicated the patient was hospitalized. Abdominal Pain Fever SERIOUS SIDE EFFECTS: Kidney damage 14,684 ADVERSE REPORTS Pancreatitis 765 INCREASED BLOOD GLUCOSE Pancreatic cancer Liver cancer 625 PANCREATITIS Thyroid cancer 455 HYPERGLYCAEMIA 1,942 HOSPITALIZATION 2013 The JAMA Internal Medicine published a study of 1,269 patients with type-2 diabetes who filled at least one prescription for a diabetes drug in a three-year period. Out of the 145 patients who developed pancreatitis 87 of them were taking Januvia or Byetta. Therefore, Januvia and Byetta almost doubled the risk of pancreatitis compared to other diabetes drugs. Call d'Oliveira & Associates at 1-800-992-6878 for a free consultation